A Phase II Study of Intravenous Azacitidine Alone in Patients With Myelodysplastic Syndromes

Clinical trial NCT00384956 · COMPLETED

Trial details

NCT number: NCT00384956
Sponsor: Washington University School of Medicine
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndromes

Start date: 2006-08-01
Primary completion: 2008-08-01
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.